Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions for transforming discovery, clinical research, and diagnostics i...
QTRX: Diagnostics and clinical trials growth, new leadership, and synergy gains drive optimism for 2024
Quanterix Corp 2026: Revenue $32.91M, EPS ($1.04) — 10-Q Summary
Quanterix To Report First Quarter 2026 Financial Results on May 6, 2026 | QTRX Stock News
Quanterix To Report Fourth Quarter and Full Year 2025 Financial Results on March 2, 2026 | QTRX Stock News